SII’s MenFive receives WHO prequalification EP News Bureau Jul 13, 2023 MenFive is currently undergoing an additional Phase 3 study in healthy children between 9 and 15 months of age in Mali, to examine…
SII restarts manufacturing of COVISHIELD PTI Apr 14, 2023 Adar Poonawalla informs that the company already has six million booster doses of Covovax vaccine available and adults must take…
SII likely front-runner to win supply of HPV vaccines for Universal Immunisation Program: GlobalData EP News Bureau Mar 21, 2023 Currently, the Serum Institute of India is the only domestic player that was able to launch its homegrown HPV vaccine, 'Cervavac',…
Cooperation needed among multi-lateral organisations to deal with future outbreaks: Adar Poonawalla PTI Jan 23, 2023 Speaking during the World Economic Forum (WEF) Annual Meeting 2023, Poonawalla said he is optimistic about the cooperation
SII seeks inclusion of COVID jab Covovax in CoWIN portal as heterologous booster dose for adults PTI Jan 19, 2023 The National Technical Advisery Group on Immunisation (NTAGI) is likely to hold a meeting soon to decide on the matter
Serum Institute’s free supply of Covishield to Centre : First lot of 80 lakh doses set for dispatch PTI Jan 16, 2023 Since the launch of the anti-COVID vaccination drive, SII has so far provided 170 crore doses of Covishield to the government
COVID-19: Covovax to get approval as booster in 10-15 days: Adar Poonawalla PTI Jan 11, 2023 He said everyone was looking at India, not just in terms of healthcare, but because the country managed to take care of a huge and…
Serum Institute seeks drug regulator’s approval for market authorisation of its COVID vaccine as… PTI Dec 23, 2022 The vaccine will be administered to those aged 18 years and above, and those who have been administered two doses of Covishield or…
Meeting on introduction of HPV vaccine in immunisation programme held; SII and Merck representatives… PTI Dec 19, 2022 Representatives of the Serum Institute of India (SII) and Merck were present in the meeting held last week and deliberated on…
SII manufactures and ships ebola vaccine to Uganda EP News Bureau Dec 16, 2022 The bivalent vaccine is designed to target both major strains of ebola virus